Michael T. Tetzlaff

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID: 0000-0001-7899-4138

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results”.

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2719 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Cancer Discovery(2016)10.1158/2159-8290.cd-15-1545

N/A

1.0DataRank · unranked

1012 citations

Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto +39 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

Nature Communications(2021)10.1038/s41467-020-20600-7

N/A

0.784DataRank · unranked

185 citations

Thomas Connelly, Robin Choi, Hyeree Choi, Anastasia Samarkina, Ling Li +52 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1

Nature Communications(2021)10.1038/s41467-021-24293-4

N/A

0.505DataRank · unranked

28 citations

Alphonsus H. C. Ng, Frances Chow, Richard G. Everson, Beth A. Helmink, Michael T. Tetzlaff +6 more

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Cancer Medicine(2020)10.1002/cam4.3474

N/A

0.425DataRank · unranked

16 citations

Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang +13 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0.385DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more

Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort

Annals of Oncology(2025)10.1016/j.annonc.2025.10.018

N/A

0.345DataRank · unranked

9 citations

Richard A. Scolyer, Elizabeth M. Burton, Klaus J. Busam, Kuang Yu Chen, Ashley Cimino‐Mathews +18 more

CIMAC-CIDC tissue imaging harmonization.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3125

N/A

0.269DataRank · unranked

5 citations

Edwin R. Parra, Ana Lako, Evisa Gjini, Beatriz Sánchez Espiridión, Ignacio I. Wistuba +10 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.01.034

N/A

0DataRank · unranked

4 citations

Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani +12 more

Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden

Investigative Ophthalmology & Visual Science(2024)10.1167/iovs.65.4.24

N/A

0DataRank · unranked

9 citations

Priyadharsini Nagarajan, Oded Sagiv, Curtis R. Pickering, Neil D. Gross, Jing Ning +5 more

Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

Acta Neuropathologica Communications(2025)10.1186/s40478-025-01978-1

N/A

0DataRank · unranked

1 citations

Meredith S. Pelster, Merve Hasanov, Renato Guerrieri, Courtney W. Hudgens, Debora Alejandra Ledesma +19 more

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016

N/A

0DataRank · unranked

35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000960

N/A

0DataRank · unranked

61 citations

Kathryn Bollin, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Kevin B. Kim, Jason Roszik +12 more

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10090

N/A

0DataRank · unranked

1 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +8 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation

Frontiers in Oncology(2021)10.3389/fonc.2021.631766

N/A

0DataRank · unranked

40 citations

Dai Ogata, Jason Roszik, Yong Qin, Sun‐Hee Kim, Michael T. Tetzlaff +5 more

Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases

Neuro-Oncology Advances(2021)10.1093/noajnl/vdaa177

N/A

0DataRank · unranked

27 citations

Renato Guerrieri, Qianghua Hu, Aron Y. Joon, Swaminathan Kumar, Lauren E. Haydu +9 more

High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens

Scientific Reports(2021)10.1038/s41598-021-88391-5

N/A

0DataRank · unranked

27 citations

Lauren E. Haydu, Ping Song, Jianyi Nie, Michael T. Tetzlaff, Lawrence N. Kwong +4 more

S1801: A randomized trial of adjuvant versus neoadjuvant pembrolizumab for melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps9585

N/A

0DataRank · unranked

3 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +9 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

The Journal of Experimental Medicine(2022)10.1084/jem.20221333

N/A

0DataRank · unranked

64 citations

Yusra B. Medik, Bhakti Patel, Daniel Zamler, Sijie Chen, Thomas Chapman +39 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

(2022)10.52519/00101

N/A

0DataRank · unranked

3 citations

Yusra B. Medik, Bhakti K. Patel, Daniel B. Zamler, Sijie Chen, T. Chapman +39 more